- Home
- BNTC vs LSAK Comparison
BNTC vs LSAK Comparison
Compare BNTC & LSAK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BNTC
- LSAK
- Stock Information
- Founded
- BNTC 1995
- LSAK 1997
- Country
- BNTC United States
- LSAK South Africa
- Employees
- BNTC N/A
- LSAK N/A
- Industry
- BNTC Biotechnology: Pharmaceutical Preparations
- LSAK Investment Bankers/Brokers/Service
- Sector
- BNTC Health Care
- LSAK Finance
- Exchange
- BNTC Nasdaq
- LSAK Nasdaq
- Market Cap
- BNTC 335.5M
- LSAK 344.5M
- IPO Year
- BNTC N/A
- LSAK N/A
- Fundamental
- Price
- BNTC $13.24
- LSAK $4.74
- Analyst Decision
- BNTC Strong Buy
- LSAK
- Analyst Count
- BNTC 5
- LSAK 0
- Target Price
- BNTC $26.00
- LSAK N/A
- AVG Volume (30 Days)
- BNTC 40.8K
- LSAK 18.6K
- Earning Date
- BNTC 09-25-2025
- LSAK 09-10-2025
- Dividend Yield
- BNTC N/A
- LSAK N/A
- EPS Growth
- BNTC N/A
- LSAK N/A
- EPS
- BNTC N/A
- LSAK N/A
- Revenue
- BNTC N/A
- LSAK $574,080,000.00
- Revenue This Year
- BNTC N/A
- LSAK $1.06
- Revenue Next Year
- BNTC N/A
- LSAK $13.32
- P/E Ratio
- BNTC N/A
- LSAK N/A
- Revenue Growth
- BNTC N/A
- LSAK 4.13
- 52 Week Low
- BNTC $8.06
- LSAK $3.39
- 52 Week High
- BNTC $17.15
- LSAK $5.60
- Technical
- Relative Strength Index (RSI)
- BNTC 59.72
- LSAK 51.59
- Support Level
- BNTC $12.57
- LSAK $4.60
- Resistance Level
- BNTC $13.33
- LSAK $4.76
- Average True Range (ATR)
- BNTC 0.60
- LSAK 0.11
- MACD
- BNTC 0.10
- LSAK -0.01
- Stochastic Oscillator
- BNTC 95.59
- LSAK 36.73
About BNTC Benitec Biopharma Inc.
Benitec Biopharma Inc is a clinical-stage biotechnology company focused on the advancement of novel genetic medicines. Its technology has the potential to provide a one-shot cure for a wide range of diseases that are addressed by strict ongoing treatment regimens or that have no effective treatment or only palliative care options. The Company is developing a silence and replace-based therapeutic (BB-301) for the treatment of Oculopharyngeal Muscular Dystrophy (OPMD), a chronic, life threatening genetic disorder.
About LSAK Lesaka Technologies Inc.
Lesaka Technologies Inc provides payment solutions, transaction processing solutions, and financial technologies. The company operates two reportable segments: Merchant and Consumer. The company operates mainly within South Africa. The Merchant segment that derives majority revenue includes activities related to the provision of goods and services provided to corporate and other juristic entities. It earns fees from processing activities performed for its customers and revenue generated from the distribution of prepaid airtime. The Consumer segment includes activities related to the provision of financial services to customers, including bank accounts, loans, and insurance products. The firm charges monthly administration fees for all bank accounts.